CBS1117
CBS1117 is a virus entry inhibitor with an IC50 of 70 nM for influenza A virus, A/Puerto Rico/8/34 (H1N1) . CBS1117 interferes with the hemagglutinin (HA) -mediated fusion process[1].
Product Specifications
CAS Number
959245-08-0
UNSPSC
12352005
Target
Influenza Virus
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/cbs1117.html
Purity
99.76
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
CC(C)N1CCC(NC(C2=C(Cl)C=CC=C2Cl)=O)CC1
Molecular Formula
C15H20Cl2N2O
Molecular Weight
315.24
References & Citations
[1]Hussein AFA, et al. Identification of entry inhibitors with 4-aminopiperidine scaffold targeting group 1 influenza A virus. Antiviral Res. 2020 May;177:104782.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6261938-01 0.1 mL
SLAMF1 (Signaling Lymphocytic Activation Molecule, CDw150, IPO-3, CD150, SLAM) (FITC)
Sign In for Pricing
View Details MBS6261938-02 5x 0.1 mL
SLAMF1 (Signaling Lymphocytic Activation Molecule, CDw150, IPO-3, CD150, SLAM) (FITC)
Sign In for Pricing
View Details 
C8929-05A1-ML405 100 µL
CYP7B1, ID (Cytochrome P450 7B1, 25-hydroxycholesterol 7-alpha-hydroxylase, Oxysterol 7-alpha-hydroxylase) (MaxLight 405) discontinued
Sign In for Pricing
View Details 